Form 4: Shantanu Narayen Reports Acquisition of Pfizer Phantom Stock Units

Director Shantanu Narayen reports acquisition of phantom stock units in Pfizer, reflecting deferred compensation.

Summary

• Shantanu Narayen, a director of Pfizer Inc., filed a Form 4 on October 2, 2024, reporting a transaction that occurred on September 30, 2024.
• The transaction involved the acquisition of 1,727.713 phantom stock units, representing deferred director's compensation.
• These units, including dividend equivalents, will be settled in cash or common stock at Narayen's election upon retirement from the Board of Directors.
• The price per unit is $28.94.
• Following the reported transaction, Narayen beneficially owns 150,380.466 shares of common stock directly.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard compensation practices and aligns director interests with the company's performance.

Positives

• The acquisition of phantom stock units aligns the director's interests with the long-term performance of the company.
• Deferred compensation plans can be tax-efficient for both the company and the executive.

Future Outlook

The phantom stock units will be settled in cash or common stock at the director's election following retirement from the Board of Directors.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates compensation practices for board members.

Comparison to Industry Standards

• Deferred compensation in the form of phantom stock units is a common practice among publicly traded companies to align director and executive interests with shareholder value.
• Companies like Johnson & Johnson and Merck also utilize similar compensation structures for their board members and executives.

Stakeholder Impact

• Shareholders may view this as a positive sign, as it aligns the director's interests with the company's long-term success.
• Employees are not directly impacted by this transaction.

Key Dates